Abstract:Certain microRNA (miRNA)-mRNA interactions are associated with critical biologic processes in malignant pleural mesothelioma (MPM). We wondered how miRNA interact with p53 in MPM since this tumor characteristically retains the wild-type allele which is frequently bypassed by deletion of CDKN2A. This interaction among miRNA and p53 in MPM is poorly understood. Study of this interaction could provide insights on disease mechanisms and/ or novel therapeutic strategies. We retrieved several public miRNA expression MPM data sets to perform a broad survey. We combined two meta-analyses approaches to the normalized data to maximize identifying altered miRNA specific to MPM. Then miRNAs were fit into a network where they inhibited MDM2, releasing inhibition of p53, and in turn were themselves induced by p53 (p53 regulation via a reinforcing loop). Significant miRNA of this screening algorithm were confirmed by qPCR analysis in MPM tissues and cell lines. Specific miRNAs were re-expressed in MPM cells by a lentivirus system or by mimic transfection. p53-luciferase reporter system was used to assess p53 activity. MTS assay assessed cell proliferation. Apoptotic cells were detected by Annexin-V assay. Tumorigenic characteristics of MPM cells were evaluated by clonogenicity, soft agar colony formation and 3D sphere assays. Clinical relevance of these miRNA were assessed in the TCGA MPM cohort (cancergenome.nih.gov). Our meta-analysis, revealed significant changes in several p53-regulated miRNAs. For example, miR-145 expression is repressed by 40% at steady state in MPM specimens (n=38) compared to non-malignant controls (n=21). We directly confirmed in MPM tissues a similar trend of this miRNA, while MDM2 mRNA levels were inversely higher. Next, we assessed the functional role of miR-145 in MPM cell lines with wild-type p53. Using a lentiviral expression system to sustain elevations in miR-145 levels, MDM2 transcript and protein levels were repressed, leading to increases in p53 protein and its transcriptional activity. We observed in miR-145-overexpressed MPM cell lines more apoptosis by Annexin V assay, loss of clonogenicity, growth inhibition, and attenuated tumorigenicity. To confirm that p53 can perpetuate a positive reinforcing loop inducing miR-145, we treated a panel of MPM cells with Nutlin-3a and observed coordinated increases in p53 associated with a rise in miR-145 levels. Interestingly, at least one of these miRNA was prognostic in Kaplan-Meier modeling of overall survival. We have identified candidate miRNAs that, in part, regulate p53 activity in MPM cells. These miRNAs function as tumor suppressors. They are candidates for therapeutic validation.

Supplementary Figures from A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence

Data from A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence

A p53-Responsive MicroRNA Network Promotes Cancer Cell Quiescence

Effect of Microrna-34a in Cell Cycle, Differentiation, and Apoptosis: A Review

Supplementary Information from A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Mir-656-3p Inhibits Melanomas in Vitro and in Vivo by Inducing Senescence Via Inhibiting LMNB2

Abstract A53: Tumor suppressor microRNA miR‐34 inhibits human pancreatic and gastric cancer stem cells

Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.

Microrna-16 Represses Colorectal Cancer Cell Growth in Vitro by Regulating the P53/survivin Signaling Pathway

Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells

P3.03-010 Activation of p53 in Malignant Mesothelioma: Topic: Mesothelioma Transitional

Microrna-149*, A P53-Responsive Microrna, Functions As An Oncogenic Regulator In Human Melanoma

Advances in microRNAs and TP53 Gene Regulatory Network

Mir-150, P53 Protein And Relevant Mirnas Consist Of A Regulatory Network In Nsclc Tumorigenesis

Identification of new p53 target microRNAs by bioinformatics and functional analysis

Microrna-1827 Represses MDM2 to Positively Regulate Tumor Suppressor P53 and Suppress Tumorigenesis

Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision.

p53 represses c-Myc through induction of the tumor suppressor miR-145

Inactivation of Oncogenic Camp-Specific Phosphodiesterase 4D by Mir-139-5p in Response to P53 Activation

Mutant P53-R273h Gains New Function in Sustained Activation of EGFR Signaling Via Suppressing Mir-27A Expression